%0 Journal Article
%T Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report.
%A Corrigan M
%A Haydon G
%A Thompson F
%A Rajoriya N
%A Peplow CL
%A Hubscher SG
%A Steven N
%A Hirschfield GM
%A Armstrong MJ
%J JHEP Rep
%V 1
%N 1
%D May 2019
%M 32039353
%F 9.917
%R 10.1016/j.jhepr.2019.02.001